Literature DB >> 28545320

The influence of pain-related beliefs on physical activity and health attitudes in patients with claudication: A pilot study.

Sherene E Sharath1, Panos Kougias2,3, Neal R Barshes2,3.   

Abstract

We examined how pain beliefs are related to symptom severity, expectations of risk/benefits, and baseline physical activity among claudicants. Eligible patients at the Michael E DeBakey Veterans Affairs Medical Center were administered questionnaires that measured: fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire [FABQ]), walking impairment, baseline physical activity, claudication type, and risk/benefit attitudes. Among 20 participants, the median age was 69 years (IQR: 66-75). In our efforts to understand how fear-avoidance beliefs influenced physical activity among people with claudication, we found that 12 out of 19 participants (63%) thought that the primary etiology of their pain was walking, while 18 (out of 20) (90%) people thought that walking would exacerbate their leg symptoms - suggesting that there was some confusion regarding the effects of walking on claudication. Those who expected that walking would benefit their symptoms more than surgery reported fewer fear-avoidance beliefs ( p=0.01), but those who believed that walking would make their leg pain worse expected greater benefit from surgery ( p=0.02). As symptom severity increased, fear-avoidance beliefs also increased ( p=0.001). The association between symptom severity and fear-avoidance beliefs indicates that as pain or impairment increases, the likelihood of avoiding behaviors that are thought to cause pain might also increase. Accounting for pain-related beliefs when recommending physical activity for claudication should be considered.

Entities:  

Keywords:  claudication; fear-avoidance beliefs; peripheral artery disease (PAD); physical activity

Mesh:

Year:  2017        PMID: 28545320     DOI: 10.1177/1358863X17709944

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  8 in total

1.  Patient perspectives on claudication: An opportunity to improve the adoption and adherence of exercise therapy.

Authors:  Erica N Schorr; Ryan J Mays
Journal:  Vasc Med       Date:  2017-08-10       Impact factor: 3.239

2.  L'exercice contre la maladie artérielle périphérique.

Authors:  Arthur A Qi; Christina S Korownyk
Journal:  Can Fam Physician       Date:  2022-04       Impact factor: 3.275

3.  Exercise for peripheral artery disease.

Authors:  Arthur A Qi; Christina S Korownyk
Journal:  Can Fam Physician       Date:  2022-04       Impact factor: 3.275

4.  Patient perspectives of ankle-foot orthoses for walking ability in peripheral artery disease: A qualitative study.

Authors:  Elizabeth A Choma; Ryan J Mays; Ryan L Mizner; Anita M Santasier
Journal:  J Vasc Nurs       Date:  2020-08-10

5.  Satisfaction and Acceptability of Telemonitored Home-Based Exercise in Patients With Intermittent Claudication: Pragmatic Observational Pilot Study.

Authors:  Nils Cornelis; Roselien Buys; Tijl Dewit; Dries Benoit; Jomme Claes; Inge Fourneau; Véronique Cornelissen
Journal:  JMIR Rehabil Assist Technol       Date:  2021-03-22

6.  The association between pain, balance, fall, and disability in patients with lumbar spinal stenosis with vascular claudication.

Authors:  Musa Güneş; Tarık Özmen; Tuğba Moralı Güler
Journal:  Korean J Pain       Date:  2021-10-01

7.  Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program.

Authors:  Ukachukwu Abaraogu; Elochukwu Ezenwankwo; Philippa Dall; Garry Tew; Wesley Stuart; Julie Brittenden; Chris Seenan
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

8.  Living a burdensome and demanding life: A qualitative systematic review of the patients experiences of peripheral arterial disease.

Authors:  Ukachukwu Okoroafor Abaraogu; Elochukwu Fortune Ezenwankwo; Philippa Margaret Dall; Chris Andrew Seenan
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.